Oxygen Toxicity: Mechanisms in Humans
Launched by DUKE UNIVERSITY · Feb 27, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Oxygen Toxicity: Mechanisms in Humans," is focused on understanding how certain factors can affect the risk of oxygen toxicity in scuba divers. Researchers want to learn how training the muscles we use to breathe, environmental conditions like lack of sleep and exposure to carbon dioxide, and being underwater may influence this risk. By studying these factors, the trial aims to improve our understanding of how oxygen toxicity can occur and what can be done to prevent it.
To participate, you must be a healthy adult aged 18 to 45, with equal numbers of men and women included. Participants will need to complete a health screening, engage in regular breathing exercises, and perform workouts both on land and underwater, sometimes while experiencing factors like sleep deprivation or carbon dioxide exposure. The researchers will compare how participants perform and breathe before and after these activities to see if there are any changes. If you're interested in learning more about how your body responds to different conditions while diving, this trial might be a great opportunity!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Equal numbers of male and female
- • Non-smokers
- • Aged 18-45 years
- • Males will be required to have VO2 peak \> or equal to mL/kg min
- • and females \> or equal to 30 mL/kg min
- Exclusion Criteria:
- • Pregnancy
- • Cardiorespiratory disease, including hypertension
- • Neuromuscular disease
- • Anemia
- • History of hemoglobinopathy, including sick cell disease and trait
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Derek B Covington, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials